Timing Pharmaceutical Co

Timing Pharmaceutical Co EBITDA per Employee

The EBITDA per Employee of Timing Pharmaceutical Co (6659.TWO) as of Oct 20, 2026 is 135,504.08 TWD. In the previous year, EBITDA per Employee was 194,577.55 TWD — a change of -30.36% (lower).

EBITDA per Employee

135,504.08TWD

YoY

-30.36%

Last updated:

EBITDA per Employee of Timing Pharmaceutical Co is 2024 135,504.08 TWD. EBITDA per Employee of Timing Pharmaceutical Co was 2023 194,577.55 TWD. It decreases by -30.36% lower compared to the previous year.

The Timing Pharmaceutical Co EBITDA per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Employee
Date
EBITDA per Employee
Jan 1, 2022
165,759.18 TWD
Jan 1, 2023
194,577.55 TWD
Jan 1, 2024
135,504.08 TWD
The Timing Pharmaceutical Co EBITDA per Employee history
YEAREBITDA per EmployeeYoY
135,504.08TWD-30.36%
194,577.55TWD+17.39%
165,759.18TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Timing Pharmaceutical Co Stock analysis

What does Timing Pharmaceutical Co do? Timing Pharmaceutical Co Ltd generates revenue through manufacturing concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations for domestic and overseas markets. The company accepts applications for licenses and permits related to Chinese medicine, food, and pharmaceutical products, and offers contract manufacturing services. Its comprehensive sales network covers Chinese medicine hospitals and major pharmacies across Taiwan, supported by a professional supply chain and service network. The firm also provides testing services and CDMO services for new pilot projects in research and development. The primary buyers of Timing Pharmaceutical's products include Chinese medicine hospitals, major pharmacies, and overseas markets. Domestic sales are facilitated through a full-fledged professional supply chain and service network, while overseas markets are served through direct exports and partnerships. The company's focus on traditional Chinese medicine and pharmaceuticals drives demand from healthcare institutions and consumers seeking natural health solutions. Timing Pharmaceutical Co Ltd invests annually in research and development for new pilot projects, which are supported by its contract research and development and manufacturing organization (CDMO) services. These services are contracted by clients seeking to develop and manufacture pharmaceutical products, including traditional Chinese medicine formulations. The company's portfolio includes concentrated Chinese medicine preparations, health foods, and traditional Chinese medicine formulations, all of which are distributed through its established network. Timing Pharmaceutical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Timing Pharmaceutical Co stock

EBITDA per Employee of Timing Pharmaceutical Co is 135,504.08 TWD in 2024.

EBITDA per Employee of Timing Pharmaceutical Co changed from 194,577.55 TWD to 135,504.08 TWD, representing a -30.36% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee Timing Pharmaceutical Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's Timing Pharmaceutical Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Timing Pharmaceutical Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Timing Pharmaceutical Co